Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inari Medical Inc (NARI)

Inari Medical Inc (NARI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism

Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

NARI : 105.05 (-3.45%)
Inari Medical Announces First Patient Enrolled in FLAME Study

Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

NARI : 105.05 (-3.45%)
Inari Medical Reports Fourth Quarter and Full Year 2020 Financial Results

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

NARI : 105.05 (-3.45%)
Inari Medical Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 9, 2021 / Inari Medical Inc (NASDAQ:NARI) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 9, 2021 at 4:30 PM Eastern...

NARI : 105.05 (-3.45%)
Is Inari Medical a Buy?

Inari Medical, Inc. (NARI) has been losing momentum lately due to its lofty valuation and uncertain growth prospects, despite it making significant progress in product development and the treatment of...

NARI : 105.05 (-3.45%)
Inari Medical to Announce Fourth Quarter and Full Year 2020 Financial Results

Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced...

NARI : 105.05 (-3.45%)
Inari Medical to Present in Upcoming Investor Conferences

Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced...

NARI : 105.05 (-3.45%)
Inari Medical Announces Presentation of Positive Chronic Clot Subanalysis Results from Real World CLOUT Registry at LINC 2021

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

NARI : 105.05 (-3.45%)
Inari Medical Reports Preliminary Fourth Quarter 2020 Revenue

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

NARI : 105.05 (-3.45%)
Inari Medical's FlowTriever System Receives FDA 510(k) Clearance for Treatment of Right Atrial Clot in Transit

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

NARI : 105.05 (-3.45%)
Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") announced today that its management team will participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020.

MHMNF : 54.5000 (unch)
NARI : 105.05 (-3.45%)
Inari Medical Announces Promotion of Drew Hykes to Chief Operating Officer

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

MDT : 125.91 (+0.05%)
NARI : 105.05 (-3.45%)
Inari Medical to Participate in Upcoming Investor Conferences

Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

WFC : 43.84 (+3.79%)
NARI : 105.05 (-3.45%)
Inceptus Announces IPO Of First Portfolio Company

, /PRNewswire/ -- Inceptus Medical LLC, a medical device company incubator, announced today the closing of the initial public offering for its first portfolio company, Inari Medical, Inc.

NARI : 105.05 (-3.45%)
Inari Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

WFC : 43.84 (+3.79%)
NARI : 105.05 (-3.45%)
Inari Medical Announces Pricing of Its Upsized Initial Public Offering

Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today...

WFC : 43.84 (+3.79%)
NARI : 105.05 (-3.45%)
Inari Medical Launches Initial Public Offering

, /PRNewswire/ -- Inari Medical, Inc. ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases,...

NARI : 105.05 (-3.45%)

Barchart Exclusives

Platinum Struggles At The $1200 Level
Platinum has been trading on either side of $1200 per ounce over the past weeks. Platinum has lagged the other precious metals for years. The technical break in Q1 could lead to higher highs over the coming weeks and months. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar